These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis. Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811 [TBL] [Abstract][Full Text] [Related]
23. Demyelination and axonal damage in a non-human primate model of multiple sclerosis. Mancardi G; Hart B; Roccatagliata L; Brok H; Giunti D; Bontrop R; Massacesi L; Capello E; Uccelli A J Neurol Sci; 2001 Feb; 184(1):41-9. PubMed ID: 11231031 [TBL] [Abstract][Full Text] [Related]
24. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Kornek B; Storch MK; Weissert R; Wallstroem E; Stefferl A; Olsson T; Linington C; Schmidbauer M; Lassmann H Am J Pathol; 2000 Jul; 157(1):267-76. PubMed ID: 10880396 [TBL] [Abstract][Full Text] [Related]
25. Neural Stem Cells of the Subventricular Zone Contribute to Neuroprotection of the Corpus Callosum after Cuprizone-Induced Demyelination. Butti E; Bacigaluppi M; Chaabane L; Ruffini F; Brambilla E; Berera G; Montonati C; Quattrini A; Martino G J Neurosci; 2019 Jul; 39(28):5481-5492. PubMed ID: 31138656 [TBL] [Abstract][Full Text] [Related]
26. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination. Mullin AP; Cui C; Wang Y; Wang J; Troy E; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E Neurobiol Dis; 2017 Sep; 105():142-155. PubMed ID: 28576706 [TBL] [Abstract][Full Text] [Related]
27. Quantitative MRI and ultrastructural examination of the cuprizone mouse model of demyelination. Thiessen JD; Zhang Y; Zhang H; Wang L; Buist R; Del Bigio MR; Kong J; Li XM; Martin M NMR Biomed; 2013 Nov; 26(11):1562-81. PubMed ID: 23943390 [TBL] [Abstract][Full Text] [Related]
28. Anatomical Distribution of Cuprizone-Induced Lesions in C57BL6 Mice. Goldberg J; Clarner T; Beyer C; Kipp M J Mol Neurosci; 2015 Oct; 57(2):166-75. PubMed ID: 26067430 [TBL] [Abstract][Full Text] [Related]
35. Thyroid hormone alleviates demyelination induced by cuprizone through its role in remyelination during the remission period. Zhang M; Zhan XL; Ma ZY; Chen XS; Cai QY; Yao ZX Exp Biol Med (Maywood); 2015 Sep; 240(9):1183-96. PubMed ID: 25577802 [TBL] [Abstract][Full Text] [Related]
36. Toll-Like Receptor 2-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination. Esser S; Göpfrich L; Bihler K; Kress E; Nyamoya S; Tauber SC; Clarner T; Stope MB; Pufe T; Kipp M; Brandenburg LO Mol Neurobiol; 2018 Aug; 55(8):6237-6249. PubMed ID: 29288338 [TBL] [Abstract][Full Text] [Related]
37. Age increases axon loss associated with primary demyelination in cuprizone-induced demyelination in C57BL/6 mice. Irvine KA; Blakemore WF J Neuroimmunol; 2006 Jun; 175(1-2):69-76. PubMed ID: 16626812 [TBL] [Abstract][Full Text] [Related]
38. Assessment of lesion pathology in a new animal model of MS by multiparametric MRI and DTI. Boretius S; Escher A; Dallenga T; Wrzos C; Tammer R; Brück W; Nessler S; Frahm J; Stadelmann C Neuroimage; 2012 Feb; 59(3):2678-88. PubMed ID: 21914485 [TBL] [Abstract][Full Text] [Related]
39. Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus. Norkute A; Hieble A; Braun A; Johann S; Clarner T; Baumgartner W; Beyer C; Kipp M J Neurosci Res; 2009 May; 87(6):1343-55. PubMed ID: 19021291 [TBL] [Abstract][Full Text] [Related]